Clinical Trials Directory

Trials / Unknown

UnknownNCT03986372

The Effect of Multiple Injection of Platlet-rich Plasma in Chronic Patellar Tendinopathy

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

According to previous studies, the effect of PRP to patellar tendinopathy could last longer. However, the type, concentration, time and frequent of injection are still debated。 This study is to understand the effect of multiple injection of platlet-rich plasma in chronic patellar tendinopathy and to analyze the relation between efficacy of PRP and the growth factor in PRP.

Detailed description

Patellar tendinopathy, also known as jumper's knee,is clinically common characterised by anterior knee pain, activity-related pain、local tenderness over inferior pole of patella. The discomfort can result in decreasing athletic performance and be one of the most challenge for sports medicine doctor. The patellar tendon suffer from repetitive microtrauma,result in reactive patellar tendinopathy. The overload tendon combining with risk factors of patellar tendinopathy will not recover timely and progress to chronic patellar tendinopathy. Hence, to reverse the progression is our aim. According to previous studies, several nonsurgical treatment options have been proposed such as medication, eccentric exercise, corticosteroid injection, shockwave and platelet-rich plasma (PRP). Among all the options, the effect of PRP could last longer. However, the type, concentration, time and frequent of injection are still debated。Moreover, there is no study about the relationship between efficacy and the ratio and concentration of growth factor in the PRP. The aim of this study is to understand (1) The effect of multiple injection of platlet-rich plasma in chronic patellar tendinopathy. (2) The effect of leukocyte-rich PRP in chronic patellar tendinopathy (3) Analyze the relation between efficacy of PRP and the growth factor in PRP.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatlet-rich plasmaMultiple Platlet-rich plasma injection.

Timeline

Start date
2019-08-20
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2019-06-14
Last updated
2022-03-16

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03986372. Inclusion in this directory is not an endorsement.